Previous studies have shown that FGF19 has an insulin-like regulatory function in metabolism, and a low FGF19 concentration or impairment in FGF19 signaling can lead to glucose metabolism disorders in insulin-resistant and T2DM patients [11, 12]. The gene discussed is FGF19; the disease is glucose metabolism disease.